药物对比
Acarbose vs Sotagliflozin
比较Acarbose（Precose）与Sotagliflozin（Inpefa）治疗2型糖尿病及心力衰竭：作用机制、用途、副作用，以及需与您的医生讨论的主要差异。
此页面暂无可用的对比维度。
临床背景
This comparison arises for type 2 diabetes patients who also have heart failure or cardiovascular risk, balancing glycemic control against cardiorenal protection.
结论
Neither is universally better; Sotagliflozin offers CV/HF benefits while Acarbose focuses on postprandial glucose with distinct side-effect profiles.
全部药物对比